Cargando…
ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susce...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793589/ https://www.ncbi.nlm.nih.gov/pubmed/33523981 http://dx.doi.org/10.1126/sciadv.aba7381 |
_version_ | 1783634022728990720 |
---|---|
author | Pihl, Rasmus Jensen, Rasmus K. Poulsen, Emil C. Jensen, Lisbeth Hansen, Annette G. Thøgersen, Ida B. Dobó, József Gál, Péter Andersen, Gregers R. Enghild, Jan J. Thiel, Steffen |
author_facet | Pihl, Rasmus Jensen, Rasmus K. Poulsen, Emil C. Jensen, Lisbeth Hansen, Annette G. Thøgersen, Ida B. Dobó, József Gál, Péter Andersen, Gregers R. Enghild, Jan J. Thiel, Steffen |
author_sort | Pihl, Rasmus |
collection | PubMed |
description | Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susceptible region, enabling ITIH4 to function as a protease inhibitor. This is exemplified by its inhibition of mannan-binding lectin–associated serine protease-1 (MASP-1), MASP-2, and plasma kallikrein, which are key proteases for intravascular host defense. Mechanistically, ITIH4 acts as bait that, upon cleavage, forms a noncovalent, inhibitory complex with the executing protease that depends on the ITIH4 von Willebrand factor A domain. ITIH4 inhibits the MASPs by sterically preventing larger protein substrates from accessing their active sites, which remain accessible and fully functional toward small substrates. Thus, we demonstrate that ITIH4 functions as a protease inhibitor by a previously undescribed inhibitory mechanism. |
format | Online Article Text |
id | pubmed-7793589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-77935892021-01-15 ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism Pihl, Rasmus Jensen, Rasmus K. Poulsen, Emil C. Jensen, Lisbeth Hansen, Annette G. Thøgersen, Ida B. Dobó, József Gál, Péter Andersen, Gregers R. Enghild, Jan J. Thiel, Steffen Sci Adv Research Articles Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susceptible region, enabling ITIH4 to function as a protease inhibitor. This is exemplified by its inhibition of mannan-binding lectin–associated serine protease-1 (MASP-1), MASP-2, and plasma kallikrein, which are key proteases for intravascular host defense. Mechanistically, ITIH4 acts as bait that, upon cleavage, forms a noncovalent, inhibitory complex with the executing protease that depends on the ITIH4 von Willebrand factor A domain. ITIH4 inhibits the MASPs by sterically preventing larger protein substrates from accessing their active sites, which remain accessible and fully functional toward small substrates. Thus, we demonstrate that ITIH4 functions as a protease inhibitor by a previously undescribed inhibitory mechanism. American Association for the Advancement of Science 2021-01-08 /pmc/articles/PMC7793589/ /pubmed/33523981 http://dx.doi.org/10.1126/sciadv.aba7381 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Research Articles Pihl, Rasmus Jensen, Rasmus K. Poulsen, Emil C. Jensen, Lisbeth Hansen, Annette G. Thøgersen, Ida B. Dobó, József Gál, Péter Andersen, Gregers R. Enghild, Jan J. Thiel, Steffen ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism |
title | ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism |
title_full | ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism |
title_fullStr | ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism |
title_full_unstemmed | ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism |
title_short | ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism |
title_sort | itih4 acts as a protease inhibitor by a novel inhibitory mechanism |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793589/ https://www.ncbi.nlm.nih.gov/pubmed/33523981 http://dx.doi.org/10.1126/sciadv.aba7381 |
work_keys_str_mv | AT pihlrasmus itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT jensenrasmusk itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT poulsenemilc itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT jensenlisbeth itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT hansenannetteg itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT thøgersenidab itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT dobojozsef itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT galpeter itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT andersengregersr itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT enghildjanj itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism AT thielsteffen itih4actsasaproteaseinhibitorbyanovelinhibitorymechanism |